UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000004458
Receipt number R000005337
Scientific Title Phase III trial evaluating the role of continuous letrozole versus intermittent letrozole following 4 to 6 years of prior adjuvant endocrine therapy for postmenopausal women with hormone-receptor positive, node positive early stage breast cancer
Date of disclosure of the study information 2010/11/01
Last modified on 2021/11/11 17:17:06

No. Disposal Last modified on Item of update
1 Insert 2010/10/27 14:19:07
2 Update 2012/05/02 10:44:38 Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2012/09/12 15:52:33 Recruitment status
4 Update 2013/10/29 13:21:38 Email
Institutions
5 Update 2013/10/29 13:36:00 Institutions
6 Update 2014/10/30 13:55:36 Address
Address
TEL
Address
Address
TEL
7 Update 2014/10/30 13:59:17 Key inclusion criteria
8 Update 2016/05/09 09:17:57 Name of primary person or sponsor
Organization
9 Update 2018/08/17 10:29:22 Acronym
Acronym
10 Update 2018/08/23 17:39:21 Public title
11 Update 2018/08/24 10:05:09 UMIN ID1
12 Update 2020/05/14 15:23:06 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Organization
Organization
Organization
Organization
Address
Address
Tel
Email
13 Update 2021/08/24 14:49:40 Recruitment status
Date of IRB
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
14 Update 2021/08/24 15:36:52 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
15 Update 2021/08/26 15:18:25 Recruitment status
16 Update 2021/08/27 13:25:34
Last name of contact person

Last name of contact person
Name of person sending information
Name of person sending information
17 Update 2021/11/11 17:17:06 Results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures